This brand name is authorized in France, United Kingdom
The drug NEGABAN contains one active pharmaceutical ingredient (API):
1
Temocillin
UNII 96IIP39ODH - TEMOCILLIN SODIUM
|
Temocillin is an antibiotic active in vitro against many aerobic gram-negative bacteria, with the notable exception of Pseudomonas aeruginosa and Acinetobacter spp. ฮฒ-lactam antibiotics irreversibly bind to the active site of specific transpeptidases and carboxypeptidases known as Penicillin Binding Proteins (PBP), preventing peptidoglycan production. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
NEGABAN Powder for solution for injection/infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
J01CA17 | Temocillin | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01C Beta-lactam antibacterials, penicillins → J01CA Penicillins with extended spectrum |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: FR | Base de donnรฉes publique des mรฉdicaments | Identifier(s): 62424059, 64732109 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 95494 |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.